LONDON--(BUSINESS WIRE)--Gyroscope Therapeutics Limited, a clinical-stage gene therapy company focused on treating diseases of the eye, announced today it has raised USD $148.0 million (£107.8 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback